# Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pneumonitis-in-patients-treated-with-anti-programmed-death-1-programmed-death/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jarushka Naidoo,Xuan Wang,Kaitlin M. Woo,Tunç Iyriboz,Darragh Halpenny,Jane Cunningham,Jamie E. Chaft,Neil H. Segal,Margaret K. Callahan,Alexander M. Lesokhin,Jonathan E. Rosenberg,Martin H. Voss,Charles M. Rudin,Hira Rizvi,Xue Hou,Katherine Rodríguez,Melanie Albano,Ruth-Ann Gordon,Charles Leduc,Natasha Rekhtman,Bianca Harris,Alexander M. Menzies,Alexander Guminski,Matteo S. Carlino,Benjamin Y. Kong,Jedd D. Wolchok,Michael A. Postow,Georgina V. Long,Matthew D. Hellmann |
| Citations | 1,213 |
| DOI | 10.1200/jco.2016.68.2005 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/5559901 |
| OpenAlex ID | https://openalex.org/W2522337762 |
| PMID | 27646942 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Charles M. Rudin](https://scholariq.org/researchers/charles-m-rudin/)
- [Natasha Rekhtman](https://scholariq.org/researchers/natasha-rekhtman/)
- [Matthew D. Hellmann](https://scholariq.org/researchers/matthew-d-hellmann/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.